Small-Molecule Injectable Market Envisions a Striking Reach of US$ 131.70 Billion by 2033-FMI Projection

Small-molecule injectables, comprising a diverse range of pharmaceuticals with low molecular weight, are gaining prominence for their efficacy and versatility in treating various medical conditions. This market’s expansion is fueled by factors such as the rising prevalence of chronic diseases, advancements in drug development, and the increasing demand for targeted therapeutic interventions. The convenience of …